Nature’s Sunshine Products (NASDAQ:NATR – Get Free Report) and Xenetic Biosciences (NASDAQ:XBIO – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, dividends, risk, earnings and valuation.
Earnings & Valuation
This table compares Nature’s Sunshine Products and Xenetic Biosciences”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Nature’s Sunshine Products | $489.79 million | 0.80 | $19.52 million | $1.10 | 20.26 |
| Xenetic Biosciences | $2.98 million | 2.39 | -$2.68 million | ($1.20) | -2.59 |
Volatility & Risk
Nature’s Sunshine Products has a beta of 0.95, indicating that its share price is 5% less volatile than the S&P 500. Comparatively, Xenetic Biosciences has a beta of 2.2, indicating that its share price is 120% more volatile than the S&P 500.
Insider & Institutional Ownership
79.4% of Nature’s Sunshine Products shares are held by institutional investors. Comparatively, 15.1% of Xenetic Biosciences shares are held by institutional investors. 3.1% of Nature’s Sunshine Products shares are held by insiders. Comparatively, 7.6% of Xenetic Biosciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Profitability
This table compares Nature’s Sunshine Products and Xenetic Biosciences’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Nature’s Sunshine Products | 4.06% | 14.67% | 9.27% |
| Xenetic Biosciences | -70.03% | -42.43% | -35.67% |
Analyst Ratings
This is a summary of recent recommendations and price targets for Nature’s Sunshine Products and Xenetic Biosciences, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Nature’s Sunshine Products | 0 | 0 | 3 | 0 | 3.00 |
| Xenetic Biosciences | 1 | 0 | 0 | 0 | 1.00 |
Nature’s Sunshine Products presently has a consensus price target of $35.00, suggesting a potential upside of 57.02%. Given Nature’s Sunshine Products’ stronger consensus rating and higher possible upside, research analysts plainly believe Nature’s Sunshine Products is more favorable than Xenetic Biosciences.
Summary
Nature’s Sunshine Products beats Xenetic Biosciences on 11 of the 14 factors compared between the two stocks.
About Nature’s Sunshine Products
Nature’s Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature’s Sunshine and Synergy WorldWide brands through a sales force of independent consultants. Nature’s Sunshine Products, Inc. was founded in 1972 and is headquartered in Lehi, Utah.
About Xenetic Biosciences
Xenetic Biosciences, Inc. is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The Company is initially advancing cell-based therapeutics targeting the unique B-cell receptor on the surface of an individual patient’s malignant tumor cells for the treatment of B-cell lymphomas. XCART has the potential to fuel a robust pipeline of therapeutic assets targeting high-value oncology indications.
Receive News & Ratings for Nature's Sunshine Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nature's Sunshine Products and related companies with MarketBeat.com's FREE daily email newsletter.
